Terranueva Corporation

TEQ

CA88105H1010

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange Other stock markets 01:10:25 06/02/2024 am IST			5-day change	1st Jan Change
0.03 ^CAD	+50.00%		-.--%	+20.00%

2023	Terranueva Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	CI
2023	Terranueva Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	CI

Terranueva Corporation Approves Appointment of Marianne Fortier-Landry as Director

April 15, 2022 at 12:52 am IST

Terranueva Corporation at its annual and special meeting of shareholders held on April 14, 2022 approved appointment of Marianne Fortier-Landry as director.

Latest news about Terranueva Corporation

Terranueva Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	24/23/24	CI
Terranueva Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	30/23/30	CI
Terranueva Corporation Auditor Raises 'Going Concern' Doubt	05/23/05	CI
Terranueva Corporation Reports Earnings Results for the First Quarter Ended December 31, 2022	05/23/05	CI
Terranueva Corporation Reports Earnings Results for the Full Year Ended September 30, 2022	05/23/05	CI
Terranueva Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	04/22/04	CI
Terranueva Corporation announced that it has received CAD 2.95 million in funding	13/22/13	CI
Terranueva Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	26/22/26	CI
Terranueva Corporation Approves Appointment of PricewaterhouseCoopers LLP as Auditor	15/22/15	CI
Terranueva Corporation Approves Appointment of Marianne Fortier-Landry as Director	15/22/15	CI
Terranueva Corporation Reports Earnings Results for the First Quarter Ended December 31, 2021	19/22/19	CI
Terranueva Corporation Reports Earnings Results for the Full Year Ended September 30, 2021	29/22/29	CI
Terranueva Corporation Auditor Raises 'Going Concern' Doubt	28/22/28	CI
Terranueva Corporation Reports Earnings Results for the Third Quarter Ended June 30, 2021	07/21/07	CI
Terranueva Corporation Reports Earnings Results for the Second Quarter Ended March 31, 2021	28/21/28	CI
Terranueva Corporation Appoints Jean-Luc Landry as Chief Executive Officer	27/21/27	CI
Terranueva Corporation Announces Board and Executive Changes	27/21/27	CI
Terranueva Gets an Additional $500,000 in Financial Support from Canada Economic Development	07/21/07	CI
Terranueva Corporation announced that it has received CAD 1.05 million in funding	22/21/22	CI
Terranueva Corporation Auditor Raises 'Going Concern' Doubt	28/21/28	CI
Terranueva Corporation Reports Earnings Results for the Full Year Ended September 30, 2020	28/21/28	CI
Terranueva Corporation Announces New Organizational Structure	02/20/02	CI
Terranueva Corporation Announces New Organizational Structure	02/20/02	CI
Terranueva Corporation Obtains $500,000 in Financial Support from Economic Development Canada	25/20/25	CI
Corporation Terranueva Announces That It Has Files Licence Amendment Request with Health Canada	04/20/04	CI

Terranueva Corporation is a Canada-based cannabis company. The Company is focused on providing medicinal and recreational cannabis to the Canadian and international markets. It is engaged in research and development focused on the cannabis industry. The Company is also focused on implementing a modular production approach in its process automation. The Companyâs wholly owned subsidiary is Terranueva Pharma Corporation.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
TERRANUEVA CORPORATION	+20.00%	10.1L
MODERNA, INC.	+37.76%	5.25TCr
IQVIA HOLDINGS INC.	-7.47%	3.9TCr
LONZA GROUP AG	+36.64%	3.93TCr
ICON PUBLIC LIMITED COMPANY	+11.93%	2.62TCr
CELLTRION, INC.	-11.17%	2.66TCr
ALNYLAM PHARMACEUTICALS, INC.	+16.45%	2.82TCr
UNITED THERAPEUTICS CORPORATION	+45.05%	1.42TCr
MEDPACE HOLDINGS, INC.	+33.13%	1.26TCr
BIO-TECHNE CORPORATION	-3.46%	1.17TCr